TL;DR

CDMOs (development plus manufacturing) carry broader exposure than CMOs (manufacturing only): development services trigger professional liability and IP defense that pure manufacturing does not. CDMO products liability towers are typically $5M to $10M; CMO can sometimes operate on $2M to $5M. Both need the same sponsor MSA endorsements, but CDMOs face additional D&O and tech E&O exposure from the development side.

Contract manufacturing comparison

CDMO vs CMO insurance. The "D" adds a whole coverage line.

The labels are used interchangeably in the industry, but the insurance implications are not. A pure CMO executes manufacturing against sponsor specifications. A CDMO adds development services - formulation, analytical method development, scale-up engineering, sometimes regulatory submission support - which introduce errors-and-omissions exposure that products liability policies typically exclude.

The most common program failure: a CMO adds development services to its scope of work without adding professional liability / E&O coverage. The CGL/products policy covers physical product defects, but a failed batch caused by a formulation error or a missed analytical method qualification produces pure economic loss - uncovered by standard manufacturing forms.

Side-by-side

Ten dimensions where the programs differ.

Dimension

Pure CMO

CDMO

Scope of services

Manufacturing only. Sponsor provides the formulation, analytical methods, and regulatory submissions. CMO executes per spec.

Development plus manufacturing. CDMO formulates, develops analytical methods, scales up, manufactures, and often supports regulatory filings.

Primary liability theory

Products liability for manufacturing defects. Manufacturing-execution failures (out-of-spec, contamination) drive claims.

Products liability plus professional liability / E&O. Errors in formulation or method development create economic-loss exposure that products policies typically exclude.

Professional liability / E&O

Often skipped. Sponsor owns development risk. Some MSAs require modest E&O ($1M-$2M) but it is rarely friction.

Required as a standalone coverage line. $1M-$5M claims-made typical, sized to development scope and revenue. Carriers price based on the volume and class of development work.

Products liability tower

$5M-$10M occurrence is the standard sponsor MSA requirement. Limits driven by product class and revenue.

Same as CMO - products tower limits do not change because of development scope. The development services need separate E&O.

Property coverage

Manufacturing property forms sized to facility, equipment, and in-process inventory.

Same plus development assets - analytical instruments, formulation equipment, pilot-scale gear. Often higher property values per square foot than a pure manufacturer.

Sponsor MSA insurance schedule

Standard pharma contract manufacturer schedule - CGL, products, workers comp, auto, umbrella, additional insured, primary/non-contributory.

Same schedule. Sponsor MSAs typically do not separately require E&O - the CDMO carries it for its own protection against scope-creep claims.

Indemnity exposure

Indemnity scoped to manufacturing acts. Indemnity-capped-at-insurance is more achievable.

Indemnity often scoped broader to include development errors. Caps are harder to negotiate because the sponsor sees uncapped development liability as a control mechanism.

Workers compensation

Statutory plus $1M employers liability. Class codes reflect manufacturing.

Same. CDMO development staff (formulators, analytical chemists) ride on existing manufacturer class codes - usually no premium impact.

Cyber & IP

Cyber sized to PHI / sponsor confidential data volume. IP exposure is limited.

Higher cyber and IP exposure. Sponsor formulation IP, analytical method IP, and process know-how all flow through CDMO systems. $3M-$10M cyber typical; standalone IP infringement coverage sometimes added.

Typical annual premium (Texas, $20M revenue)

$45,000 to $110,000 depending on product class.

$55,000 to $140,000 - the development services premium adds $10,000-$30,000 to a comparable CMO program.

The economic-loss gap

Failed batches don't always involve a defective product.

The classic CDMO claim is a failed development batch that did not produce a physical product defect - the batch simply did not meet sponsor specifications because of a formulation or analytical-method error. The sponsor suffers economic loss: wasted API, lost shelf-life, regulatory submission delays, missed launch dates. Products liability policies exclude pure economic loss; only professional liability / E&O picks it up.

The fix is straightforward: a $1M-$5M claims-made E&O policy with a retroactive date set to before the CDMO's first development engagement. The premium is modest ($5,000-$25,000 annual) and the coverage gap it closes is consequential.

Frequently asked

Common questions about CDMO vs CMO

Is CDMO insurance different from CMO insurance?

In practice the terms are used interchangeably, but the insurance implications differ. A pure CMO (contract manufacturer) executes manufacturing only and typically needs products liability, property, and basic professional liability. A CDMO (contract development and manufacturing organization) adds development services - formulation, analytical, scale-up - which require professional liability/E&O for the development work in addition to products for the manufacturing.

Does adding "development" services to a CMO change the insurance program?

Yes. Development work introduces errors-and-omissions exposure for formulation, analytical, and process design errors - failures that may not produce a physical product defect but cause economic loss to the sponsor (failed batches, regulatory submission errors, lost shelf-life). Most CGL/products policies exclude pure economic loss, so a CDMO needs a professional liability or E&O policy alongside products.

What insurance does a sponsor MSA typically require from a CDMO vs a pure CMO?

Sponsor MSAs are usually written for "contract manufacturer" and cover both CDMO and CMO arrangements identically - CGL, products, workers comp, auto, umbrella, with additional insured and primary/non-contributory wording. The difference shows up in scope-of-services language: CDMO MSAs typically reference development deliverables that the manufacturing-focused insurance program does not cover.

How does professional liability work for a CDMO?

Professional liability or E&O for a CDMO is typically written as a claims-made policy with limits of $1M-$5M, sized to the volume and risk of development work. Coverage triggers include errors in formulation, analytical method development, regulatory submission preparation, and scale-up engineering. Most sponsor MSAs do not demand it explicitly, but operating without it leaves the CDMO exposed for any non-products failure of the development services.

Are CDMO insurance premiums higher than CMO premiums?

Modestly. The professional liability/E&O premium adds $5,000-$25,000 annually depending on revenue and development scope. The products liability premium is comparable to a pure CMO at similar revenue. The bigger driver of premium is product class (sterile injectable vs oral solid dose vs biologic) rather than CDMO vs CMO designation.

Can a small CMO add development services without restructuring its insurance?

Not safely. Adding development services without adding professional liability/E&O coverage leaves a meaningful gap. Most carriers will add the E&O coverage at modest cost if the CMO has clean claims history, but it should be in place before the first development engagement begins - claims-made policies do not retroactively cover prior services unless retroactive dates are negotiated.

CDMO practice →Medical device manufacturers →Clause glossary →Run the Free Analyzer →

Free coverage review